One shot for two viruses: new combo vaccine tested in seniors
NCT ID NCT06694389
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new combination vaccine called mRNA-1083 that aims to protect against both COVID-19 and the flu with a single shot. It involved 2,457 healthy adults aged 50 and older in Japan, Taiwan, and South Korea. The main goals were to check how well the vaccine triggers an immune response and to monitor any side effects.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID-19 are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Ajou University Hospital
Suwon, 16499, South Korea
-
Chang Gung Medical Foundation - LinKou Chang Gung Memorial Hospital
Taoyuan, 333, Taiwan
-
Chonnam National University Hospital - Allergology
Gwangju, 61469, South Korea
-
Clinical Research Tokyo Hospital - Clinical Research Center
Shinjuku, Tokyo, 160-0004, Japan
-
Daido Clinic
Nagoya, Aichi-ken, 457-8511, Japan
-
Denenchofu Family Clinic
Ōta-ku, Tokyo, 145-0071, Japan
-
Dojinkinenkai Meiwa Hospital
Chiyoda-ku, Tokyo, 101-0041, Japan
-
Fukuoka Heartnet Hospital
Fukuoka, Fukuoka, 819-0002, Japan
-
Hallym University Kangnam Sacred Heart Hospital
Seoul, 07441, South Korea
-
Higashi-Shinjuku Clinic - Internal Medicine
Shinjuku, Tokyo, 169-0072, Japan
-
Hillside Clinic Jingumae
Shibuya-ku, Tokyo, 150-0001, Japan
-
Inha University Hospital
Incheon, 22332, South Korea
-
Kaohsiung Medical University - Chung-Ho Memorial Hospital
Kaohsiung City, 807, Taiwan
-
Kaohsiung Veterans General Hospital
Kaohsiung City, 813 404, Taiwan
-
Korea University Ansan Hospital
Ansan-si, 15355, South Korea
-
Korea University Guro Hospital
Seoul, 08308, South Korea
-
Kuang Tien General Hospital - Dajia
Taichung, 437, Taiwan
-
Kyungpook National University Hospital - Infectious Diseases
Daegu, South Korea
-
Medical Coporation of Yamazaki Neurotology, Rhinolaryngology Clinical
Sapporo, Hokkaido, 060-0011, Japan
-
Medical Corporation Asbo Tokyo Asbo Clinic
Chuo-ku, Tokyo, 104-0031, Japan
-
Metropolitan Clinic - Internal Medicine
Toshima-ku, Tokyo, 171-0021, Japan
-
Motomachi Takatsuka Naika Clinic - Internal Medicine
Yokohama, Kanagawa, 231-0023, Japan
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
New Medical Research System Clinic
Hachioji-shi, Tokyo, 192-0046, Japan
-
Nihonbashi Sakura Clinic
Chuo-ku, Tokyo, 103-0025, Japan
-
Nishi-Kumamoto Hospital
Kumamoto, Kumamoto, 861-4157, Japan
-
PS Clinic - Internal medicine
Fukuoka, Fukuoka, 812-0025, Japan
-
Public Health Association.Inc.
Nagoya, Aichi-ken, 453-0804, Japan
-
Sakurajyuji Medical Corporation Medimesse Sakurajyuji Clinic
Kumamoto, Kumamoto, 860-0833, Japan
-
Sato Hospital
Osaki-shi, Miyagi, 989-6143, Japan
-
Seishukai Clinic
Taito-ku, Tokyo, 111-0036, Japan
-
Seoul National University Bundang Hospital
Seongnam-si, 13620, South Korea
-
Severance Hospital, Yonsei University Health System
Seoul, 03722, South Korea
-
Shimamura Memorial Hospital
Nerima City, Tokyo, 177-0051, Japan
-
Shinei Medical Healthcare Clinic
Suginami, Tokyo, 166-0003, Japan
-
Shinwakai Adachi Kyosai Hospital - Internal Medicine
Adachi-ku, Tokyo, 120-0022, Japan
-
Souseikai Sumida Hospital
Sumida-Ku, Tokyo, 130-0004, Japan
-
Taipei Medical University - Taipei Medical University Hospital
Taipei, 110, Taiwan
-
Tenjin Sogo Clinic
Fukuoka, Fukuoka, 810-0021, Japan
-
Tokyo center clinic - Internal medicine
Chuo-ku, Tokyo, 103-0027, Japan
-
Tri-Service General Hospital - Neihu Branch - Infectious Diseases
Taipei, 114, Taiwan
-
Yokoi Medicine Clinic
Mino, Osaka, 562-0003, Japan
-
Yonsei University, Wonju Severance Christian Hospital
Wŏnju, South Korea
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Five years on: how does long COVID evolve?
- Can a targeted pill tame severe COVID-19?
- Can an organic compound tame COVID-19 in High-Risk patients?
- Could exercise retrain the heart in long COVID?
- Can a new drug shield lungs from COVID-19's worst damage?
- Can paxlovid hold the line against severe COVID-19 outside the lab?